[go: up one dir, main page]

MX2012012668A - Aplicacion de alto cizallamiento en administracion de farmaco. - Google Patents

Aplicacion de alto cizallamiento en administracion de farmaco.

Info

Publication number
MX2012012668A
MX2012012668A MX2012012668A MX2012012668A MX2012012668A MX 2012012668 A MX2012012668 A MX 2012012668A MX 2012012668 A MX2012012668 A MX 2012012668A MX 2012012668 A MX2012012668 A MX 2012012668A MX 2012012668 A MX2012012668 A MX 2012012668A
Authority
MX
Mexico
Prior art keywords
drug
therapeutic fluid
high shear
carrier
processed
Prior art date
Application number
MX2012012668A
Other languages
English (en)
Inventor
Abbas Hassan
Rayford G Anthony
Aziz Hassan
Original Assignee
Hrd Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hrd Corp filed Critical Hrd Corp
Publication of MX2012012668A publication Critical patent/MX2012012668A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/27—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices
    • B01F27/271—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator
    • B01F27/2711—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator provided with intermeshing elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/27—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices
    • B01F27/272—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed axially between the surfaces of the rotor and the stator, e.g. the stator rotor system formed by conical or cylindrical surfaces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/80—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Se describen en esta descripción, métodos y sistemas para la administración de fármacos utilizando alta cizalla. En una modalidad, un método comprende (1) someter un fluido terapéutico que contiene un fármaco a una alta cizalla, y (2) obtener un fluido procesado terapéutico, en el que el fluido terapéutico procesado contiene el fármaco en tamaño nano. En una modalidad, un método comprende (1) someter un portador del fármaco y un fluido terapéutico que contiene un fármaco a un alto cizallamiento, y (2) obtener un fluido procesado terapéutico, en el que el fluido terapéutico procesado contiene el portador del fármaco cargado con el fármaco. En una modalidad, un método comprende (1) aplicar alta cizalla a un portador del fármaco y de un fluido terapéutico que contiene un fármaco, (2) obtener un fluido terapéutico procesado, en el que el fluido terapéutico procesado contiene el portador cargado con fármaco, y (3) modificar el portador cargado con fármaco con una mitad objetivo para obtener un portador cargado de fármaco modificado.
MX2012012668A 2010-04-30 2011-04-08 Aplicacion de alto cizallamiento en administracion de farmaco. MX2012012668A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33010410P 2010-04-30 2010-04-30
US35544810P 2010-06-16 2010-06-16
PCT/US2011/031727 WO2011139479A2 (en) 2010-04-30 2011-04-08 High shear application in drug delivery

Publications (1)

Publication Number Publication Date
MX2012012668A true MX2012012668A (es) 2012-12-17

Family

ID=44858409

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012012667A MX354124B (es) 2010-04-30 2011-04-08 Aplicacion de alto cizallamiento en terapia medica.
MX2012012668A MX2012012668A (es) 2010-04-30 2011-04-08 Aplicacion de alto cizallamiento en administracion de farmaco.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2012012667A MX354124B (es) 2010-04-30 2011-04-08 Aplicacion de alto cizallamiento en terapia medica.

Country Status (13)

Country Link
US (4) US8609115B2 (es)
EP (2) EP2563426B1 (es)
JP (3) JP5759533B2 (es)
KR (3) KR20130080786A (es)
CN (3) CN102869348A (es)
AU (2) AU2011248867B2 (es)
BR (2) BR112012027651A2 (es)
CA (2) CA2797913C (es)
DK (1) DK2563426T3 (es)
EA (2) EA029314B1 (es)
ES (1) ES2663572T3 (es)
MX (2) MX354124B (es)
WO (2) WO2011139479A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012126649A (ja) * 2010-12-13 2012-07-05 Satoshi Anai 膀胱癌増殖抑制用組成物
US9421477B2 (en) * 2013-08-12 2016-08-23 Green Extraction Technologies Biomass fractionation and extraction apparatus
US10201789B2 (en) * 2013-12-27 2019-02-12 Sintokogio, Ltd. Dispersing device, a dispersing system, and a process for dispersing
HK1223975A1 (zh) * 2013-12-27 2017-08-11 水活力株式会社 含纳米气泡的组合物及其用途
JP6574785B2 (ja) * 2014-11-24 2019-09-11 有限会社中島工業 患部浸透亢進性薬剤組成物の製造方法
CN104803467A (zh) * 2015-04-24 2015-07-29 刘芮萌 一种微纳米气泡发生装置
JP6977979B2 (ja) * 2015-06-09 2021-12-08 国立大学法人大阪大学 神経損傷治療又は予防用医薬
US10011804B2 (en) * 2015-08-21 2018-07-03 Ecoxtraction, Llc Method of extracting CBD, THC, and other compounds from cannabis using controlled cavitation
MX2018010901A (es) * 2016-03-11 2018-11-09 Moleaer Inc Composiciones que contienen nano-burbujas en un vehiculo liquido.
EP3456815B1 (en) * 2016-05-13 2024-07-03 SIGMA TECHNOLOGY, Inc. Aqueous solution capable of being administered to living body, and method for producing same
US20170341980A1 (en) * 2016-05-31 2017-11-30 Noblis Therapeutics, Inc. Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity
CN105997513A (zh) * 2016-06-15 2016-10-12 魏会芳 一种粉碎煎药保温装置
GB201612925D0 (en) 2016-07-26 2016-09-07 Provensis Ltd Method and device for generating injectable foam
WO2019173387A1 (en) * 2018-03-05 2019-09-12 Demetris Yannopoulos Devices and methods to infuse gases into and out of blood
WO2019244097A1 (en) * 2018-06-22 2019-12-26 Johnson & Johnson Consumer Inc. Process for formation of emulsion containing liquid crystal structure
WO2020124263A1 (en) * 2018-12-21 2020-06-25 Nanorial Technologies Ltd. Apparatus, methods, and systems for mixing, dispersing substances
JP7157263B2 (ja) 2019-07-01 2022-10-19 オークウッド ラボラトリーズ，エル．エル．シー． ミクロスフェア及びエマルションを製造するためのシステム及び方法
US12005130B2 (en) * 2019-10-16 2024-06-11 Agitated Solutions Inc. Generating microbubbles for bubble studies
CN114845644A (zh) * 2019-12-20 2022-08-02 波士顿科学国际有限公司 药剂输送装置
US11191888B1 (en) 2020-05-18 2021-12-07 Agitated Solutions Inc. Syringe-based microbubble generator
US12097512B2 (en) 2020-06-16 2024-09-24 FineFlot Inc. System and method for saturation of a multicomponent medium with active microbubbles
WO2025012889A1 (en) * 2023-07-13 2025-01-16 Kan Eddy Quality of lifeenhancing liquid composition
CN117282303B (zh) * 2023-11-24 2024-02-06 吉林农业科技学院 一种食品乳化罐
CN120790320A (zh) * 2025-09-15 2025-10-17 湖南广安动物保健品有限公司 高速剪切机

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887167A (en) 1971-02-09 1975-06-03 Du Pont Apparatus for manufacture of organic isocyanates
ATE55056T1 (de) * 1982-12-09 1990-08-15 Advanced Drug Tech Einfach absorbierbare fettsaeureemulsionen.
GB8431012D0 (en) * 1984-12-07 1985-01-16 British Petroleum Co Plc Preparation of emulsions
US5279463A (en) 1992-08-26 1994-01-18 Holl Richard A Methods and apparatus for treating materials in liquids
US20070122465A1 (en) * 1993-02-22 2007-05-31 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
DE4428018A1 (de) 1994-08-08 1996-02-15 Bayer Ag Verfahren zur Herstellung von aromatischen Aminen
US6333021B1 (en) * 1994-11-22 2001-12-25 Bracco Research S.A. Microcapsules, method of making and their use
US6383237B1 (en) 1999-07-07 2002-05-07 Deborah A. Langer Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel compositions
US6368367B1 (en) 1999-07-07 2002-04-09 The Lubrizol Corporation Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel composition
US6368366B1 (en) 1999-07-07 2002-04-09 The Lubrizol Corporation Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel composition
US6471392B1 (en) 2001-03-07 2002-10-29 Holl Technologies Company Methods and apparatus for materials processing
US7538237B2 (en) 1999-07-02 2009-05-26 Kreido Laboratories Process for high shear gas-liquid reactions
US6742774B2 (en) 1999-07-02 2004-06-01 Holl Technologies Company Process for high shear gas-liquid reactions
US6530964B2 (en) 1999-07-07 2003-03-11 The Lubrizol Corporation Continuous process for making an aqueous hydrocarbon fuel
CA2366458A1 (en) * 2000-01-31 2001-08-16 Collaborative Technologies, Inc. Method and system for producing customized cosmetic and pharmaceutical formulations on demand
GB0119480D0 (en) * 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
JP2003160477A (ja) * 2001-09-14 2003-06-03 Nof Corp 高級脂肪族アルコールの水性組成物、製造方法および投与方法
WO2003033097A2 (en) 2001-10-17 2003-04-24 E.I. Du Pont De Nemours And Company Rotor-stator apparatus and process for the formation of particles
US7098360B2 (en) 2002-07-16 2006-08-29 Kreido Laboratories Processes employing multiple successive chemical reaction process steps and apparatus therefore
EP1540302A4 (en) 2002-09-11 2008-05-07 Kreido Lab METHOD AND DEVICES FOR MIXING AND REACTING MATERIALS WITH GREAT SHARING
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
WO2004064769A2 (en) 2003-01-21 2004-08-05 Hector Herrera Methods for making and using topical delivery agents
DE602004029010D1 (de) * 2003-02-04 2010-10-21 Bracco Suisse Sa Ultraschall kontrastmittel und verfahren zur erstellung
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
JP2008513363A (ja) * 2004-09-14 2008-05-01 ナノデル テクノロジーズ ゲーエムベーハー ナノ粒子を含む送達媒体
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
EP1829605A1 (en) * 2004-12-13 2007-09-05 Accelergy Shanghai R&D Center An apparatus for processing materials
WO2006096906A1 (en) 2005-03-18 2006-09-21 Nanomaterials Technology Pte Ltd Inhalable drug
ES2338039T3 (es) 2005-04-13 2010-05-03 ABBOTT GMBH & CO. KG Procedimiento para la obtencion cuidadosa de supensiones de particulas de elevada finura y particulas de elevada finura, asi como su aplicacion.
US8732234B2 (en) 2005-06-07 2014-05-20 Yahoo! Inc. Providing relevant non-requested content to a mobile device
US20070160658A1 (en) * 2005-10-20 2007-07-12 The Penn State Research Foundation Delivery system for diagnostic and therapeutic agents
US20070160577A1 (en) * 2005-12-06 2007-07-12 Wyeth Interleukin-11 compositions and methods of use
EP2077129A4 (en) 2006-10-23 2011-01-26 Sun Medical Scient Shanghai Co Ltd INTELLIGENT REMOTE CONTROLLED PORTABLE INTRAVENOUS INJECTION AND TRANSFUSION SYSTEM
EP2494958A1 (en) * 2006-12-01 2012-09-05 Anterios, Inc. Amphiphilic Entity Nanoparticles
EP2117603A2 (en) * 2006-12-19 2009-11-18 Bracco International B.V. Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds
US7943712B2 (en) 2006-12-28 2011-05-17 The Goodyear Tire & Rubber Company Catalyst system for synthesizing amine functionalized rubbery polymers having a high trans microstructure
US7910758B2 (en) * 2007-01-02 2011-03-22 H R D Corporation Catalytic hydrogenation process for the production of low trans fat-containing triglycerides
CN100569294C (zh) * 2007-04-13 2009-12-16 西安力邦制药有限公司 一种静脉注射用高稳定长循环脂肪乳载药制剂
US8034972B2 (en) * 2007-06-27 2011-10-11 H R D Corporation System and process for production of toluene diisocyanate
US8282266B2 (en) * 2007-06-27 2012-10-09 H R D Corporation System and process for inhibitor injection
US8461377B2 (en) * 2007-06-27 2013-06-11 H R D Corporation High shear process for aspirin production
US8034970B2 (en) * 2007-06-27 2011-10-11 H R D Corporation Method of making phthalic acid diesters
US8026403B2 (en) 2007-06-27 2011-09-27 H R D Corporation System and process for production of liquid product from light gas
US8026402B2 (en) * 2007-06-27 2011-09-27 H R D Corporation High shear process for cyclohexane production
US8445672B2 (en) 2007-06-27 2013-05-21 H R D Corporation High shear process for dextrose production
US9205388B2 (en) 2007-06-27 2015-12-08 H R D Corporation High shear system and method for the production of acids
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物
US9574155B2 (en) 2008-07-02 2017-02-21 Nanotech Lubricants, LLC Lubricant with nanodiamonds and method of making the same
EP2334353A4 (en) 2008-10-01 2013-03-27 H R D Corp USE OF SCHOOL TREATMENT FOR DISEASE TREATMENT
US20100189800A1 (en) 2009-01-23 2010-07-29 Peter Markland Continous double emulsion process for making microparticles
WO2011106565A1 (en) * 2010-02-24 2011-09-01 Travers William A Methods and devices for controlling particle size and particle size distribution
US20120070475A1 (en) * 2010-03-11 2012-03-22 Pepsico, Inc Zero Calorie Polyphenol Aqueous Dispersions
US9393198B2 (en) * 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders

Also Published As

Publication number Publication date
KR20180064560A (ko) 2018-06-14
MX354124B (es) 2018-02-14
US20140081198A1 (en) 2014-03-20
WO2011139479A2 (en) 2011-11-10
JP2013524937A (ja) 2013-06-20
US8888735B2 (en) 2014-11-18
US20110268659A1 (en) 2011-11-03
ES2663572T3 (es) 2018-04-13
KR101818659B1 (ko) 2018-01-15
EP2563426A4 (en) 2014-06-18
EA201291019A1 (ru) 2013-04-30
EA201291018A1 (ru) 2013-04-30
CA2798049A1 (en) 2011-11-10
WO2011139478A2 (en) 2011-11-10
EP2563338A2 (en) 2013-03-06
KR20130080785A (ko) 2013-07-15
US20110270156A1 (en) 2011-11-03
CN102883758A (zh) 2013-01-16
AU2011248866A1 (en) 2012-10-18
CN102869348A (zh) 2013-01-09
WO2011139478A3 (en) 2012-04-05
JP5759533B2 (ja) 2015-08-05
CN107088374A (zh) 2017-08-25
WO2011139479A3 (en) 2012-05-03
US9381138B2 (en) 2016-07-05
CN102883758B (zh) 2016-10-12
AU2011248866B2 (en) 2014-04-03
AU2011248867B2 (en) 2014-12-04
EP2563426A2 (en) 2013-03-06
US8609115B2 (en) 2013-12-17
EA029314B1 (ru) 2018-03-30
BR112012027651A2 (pt) 2016-08-16
MX2012012667A (es) 2012-12-17
JP2013527845A (ja) 2013-07-04
EP2563338A4 (en) 2014-06-18
BR112012027634A2 (pt) 2016-08-09
CA2797913C (en) 2015-06-16
US20140066852A1 (en) 2014-03-06
DK2563426T3 (en) 2018-04-16
KR20130080786A (ko) 2013-07-15
CA2797913A1 (en) 2011-11-10
CA2798049C (en) 2016-09-20
AU2011248867A1 (en) 2012-10-18
EA025125B1 (ru) 2016-11-30
JP2016019746A (ja) 2016-02-04
EP2563426B1 (en) 2018-01-03

Similar Documents

Publication Publication Date Title
MX2012012668A (es) Aplicacion de alto cizallamiento en administracion de farmaco.
EP3072506A4 (en) Carrier for drug delivery and conjugate, composition containing same, and method for administering same
AR093377A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
WO2014062697A3 (en) Drug delivery conjugates containing unnatural amino acids and methods for using
WO2011129549A3 (ko) Ph 민감성 금속 나노 입자를 이용한 항암제 전달 시스템
EP4406544A3 (en) Cellular targeted active ingredient delivery system
WO2013016363A9 (en) Multi-reservoir infusion pump systems and methods
WO2011133925A3 (en) Targeted and light-activated cytosolic drug delivery
CL2013003123A1 (es) Molécula de nucleasa híbrida; composición que comprende dicha molécula; método para preparar dicha molécula; método para tratar lupus eritematoso sistémico.
MY179194A (en) Process for preparing therapeutic nanoparticles
WO2012103257A3 (en) Transcutaneous multimodal delivery systems
WO2013067199A3 (en) Subcutaneous delivery of polymer conjugates of therapeutic agents
MX2013010376A (es) Formulaciones estables para inyeccion parenteral de farmacos de peptido.
WO2013028942A8 (en) Targeting microbubbles
MX2018001511A (es) Polimeros furtivos desordenados de forma intrinseca codificados geneticamente para suministro y metodos para usar los mismos.
EP4328314A3 (en) Lipid nanoparticle methods and compositions for producing engineered erythroid cells
GB2483505B (en) Devices for transdermal drug delivery
WO2009032737A3 (en) Systems and methods for delivering medication
WO2011106502A3 (en) Delivering drugs to desired locations within a mammal
WO2012158437A3 (en) Cannula apparatus and ventricular assist systems using the cannula apparatus
BR112017028552A2 (pt) partículas e conjugados direcionados e formulações dos mesmos
ATE470477T1 (de) Ex-vivo-verfahren zur genzuführung
WO2010065329A3 (en) Nanoparticles for cancer treatment
EP4385517A3 (en) Degarelix drug product
WO2013039621A3 (en) Methods and systems for making microtablets for drug delivery